Arcturus Therapeutics Holdings Inc.
ARCT
$10.53
$0.232.23%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -156.30% | 57.45% | 67.24% | -152.84% | -109.98% |
| Total Depreciation and Amortization | 0.49% | 10.28% | 23.34% | 56.40% | 47.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.05% | 5.39% | 17.05% | 140.39% | 26.47% |
| Change in Net Operating Assets | 1,287.50% | -4.80% | -125.09% | 116.45% | -95.91% |
| Cash from Operations | 54.85% | 26.67% | -159.33% | 84.51% | -100.39% |
| Capital Expenditure | 100.00% | 91.85% | 7.34% | 65.27% | 77.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 91.85% | 7.34% | 65.27% | 77.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -566.67% |
| Issuance of Common Stock | -90.02% | -62.34% | 2,456.38% | -- | 74.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.72% | -96.83% | 2,456.38% | 108.00% | -735.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.26% | -100.49% | -155.53% | 94.35% | -113.07% |